This independent HPLC-UV/VIS lab test confirms Retatrutide 20mg from Orbitrex Peptides at >99.80% purity. The analysis was conducted by Vanguard Laboratory on May 4, 2026.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for its potential role in metabolic regulation, weight management, and glycemic control. A purity level exceeding 99.80% indicates minimal contamination and high-grade synthesis.
The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.